In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus-Reference-Cited by-同舟云学术

In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus

Published:2006-12 Issue:4 Volume:351 Page:927-934
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Chen Ling,Liang Guang-Ping,Tang Xu-Dong,Chen Ting,Cai Yong-Guo,Fang Dian-Chun,Yu Song-Tao,Luo Yuan-Hui,Yang Shi-Ming

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference33 articles.

1. Dendritic cells and the control of immunity;Banchereau;Nature,1998

2. Dendritic cells and immune-based therapies;Steinman;Exp. Hematol.,1997

3. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells;Nair;Nature,2000

4. Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer;Su;J. Immunol.,2005

5. Cell-based vaccines for renal carcinoma: genetically-engineered tumor cells monocyte-derived dendritic cells;Frankenberger;World J. Urol.,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics;International Journal of Nanomedicine;2024-04

2. Research Advances in the Treatment of Melanoma by Treat Melanoma;Current Topics in Medicinal Chemistry;2015-09-22

3. mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity;Molecular Therapy;2015-08

4. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase;Cell Death & Disease;2014-01

5. Diepitope multiple antigen peptide of hTERT trigger stronger anti-tumor immune responses in vitro;International Immunopharmacology;2013-08